The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark
Pharmacoepidemiology and Drug Safety · 2024
DOI: 10.1002/pds.70023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Dana Backran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Retinoids, Health Knowledge, Attitudes, Practice. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
We aimed to investigate the awareness of oral retinoid teratogenicity and the adherence to the pregnancy prevention program (PPP) related to oral retinoid use by physicians, pharmacists, and patients in Denmark.
Methods
As part of the multi‐country survey, web‐based questionnaires were distributed among Danish dermatologists, general practitioners, community pharmacists, and women of childbearing age, who were using or had used oral retinoids within the past 5 years.
Results
A total of 62 physicians, 96 pharmacists, and 50 oral retinoid using women responded; 95%, 100%, and 98%, respectively, were aware of the teratogenic risks of oral retinoids. For physicians, the most applied PPP measures were the usage of the patient (44%) and the healthcare professional (19%) guides, while the least applied measure was signing medication risk awareness form (3%). Among the pharmacists, the warning sign on the outer medication package was the most used measure (45%). Among the women, a majority (90%) had read the patient information leaflet included in the medication package and 72% discussed the use of contraception with their healthcare provider, while risk awareness forms and patient cards were seen by only few.
Conclusions
In Denmark, physicians, pharmacists, and medicine users were aware about the teratogenic effects of oral retinoids. Adherence to pregnancy prevention measures varied, suggesting unwillingness to use the measures that require patients' signatures among physicians and a lack of awareness of pharmacy targeting measures. Accessibility of the latter measures need to be optimized to improve the safety of oral retinoid use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
ORCID-Profile: Johanne M Hansen, Anna Birna Almarsdóttir, Ramune Jacobsen
Zitieren
APA
Backran, D., Ahmad, S., Hansen, J. M., Almarsdóttir, A. B., & Jacobsen, R. (2024). The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70023
Vancouver
Backran D, Ahmad S, Hansen JM, Almarsdóttir AB, Jacobsen R. The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.70023
BibTeX
@article{Backran2024,
author = {Backran, Dana and Ahmad, Sophia and Hansen, Johanne M and Almarsdóttir, Anna Birna and Jacobsen, Ramune},
title = {The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
doi = {10.1002/pds.70023}
}
EUVIMED